Systematic Review
Accepted on 31 Mar 2025
The Impact of Pituitary Adenomas on Cognitive Performance: A Systematic Review
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1534635
Type at least 3 characters
453 articles
Articles
Original Research
Accepted on 24 Mar 2025
Cost-effectiveness analysis of second-line medical therapies in acromegaly: a real-life study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1573721
Review
Published on 18 Mar 2025
Oncocytic pituicytoma in a patient with Cushing’s disease: a case report and narrative literature review
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1487120
- 361 views
Editorial
Accepted on 17 Mar 2025
Research Topic Diagnosis and Treatment of Non-Functioning Pituitary Tumors
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1558988
Original Research
Accepted on 13 Mar 2025
Biomarkers of GH Deficiency Identified in Untreated and GH-Treated Pit-1 Mutant Mice
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1539797
Original Research
Accepted on 10 Mar 2025
Navigating Prognostic Strategies for GH-and PRL-Secreting Pituitary Neuroendocrine Tumors: Key Insights from a Clinicopathological Study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1541514
Original Research
Published on 24 Feb 2025
Biochemical remission, diagnostic delays, and comorbidities of acromegaly in China: a large single-centre retrospective study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1526625
- 681 views
Original Research
Published on 21 Feb 2025
Outcomes of transsphenoidal surgery for pituitary adenomas in Spain: a retrospective multicenter study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1529418
- 845 views
Original Research
Published on 07 Feb 2025
Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1534891
- 819 views
Mini Review
Accepted on 06 Feb 2025
A Case-Based Review of Adult-Onset Craniopharyngioma
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1527161
- 107 views
Original Research
Published on 03 Feb 2025
Patient perspectives on acromegaly disease burden: insights from a community meeting
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1516131
- 800 views
Original Research
Published on 31 Jan 2025
Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1516899
- 706 views
Correction
Published on 28 Jan 2025
Corrigendum: A clinical practical model for preoperative prediction of visual outcome for pituitary adenoma patients in a retrospective and prospective study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1546763
- 512 views
Original Research
Published on 15 Jan 2025
Prevalence and predictive factors of testosterone-induced erythrocytosis: a retrospective single center study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1496906
- 941 views
Original Research
Published on 23 Dec 2024
Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1511155
- 798 views
Original Research
Published on 17 Dec 2024
Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1472680
- 767 views